BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33136928)

  • 1. Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    Ruiz de Pellón Santamaría Á
    J Clin Psychopharmacol; 2020; 40(6):641-642. PubMed ID: 33136928
    [No Abstract]   [Full Text] [Related]  

  • 2. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.
    Manglik A; Wingler LM; Rockman HA; Lefkowitz RJ
    Circulation; 2020 Jul; 142(4):318-320. PubMed ID: 32412788
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?].
    Ben Dhia A; Hamzaoui S; Mouaffak F
    Encephale; 2020 Jun; 46(3S):S123-S124. PubMed ID: 32317164
    [No Abstract]   [Full Text] [Related]  

  • 5. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
    Tong TRS
    Infect Disord Drug Targets; 2020; 20(3):351. PubMed ID: 32696730
    [No Abstract]   [Full Text] [Related]  

  • 6. Cationic drugs and COVID-19.
    Brenna OV; Torretta S; Pignataro L; Di Berardino F
    Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

  • 8. Teaching Old Drugs New Tricks: Statins for COVID-19?
    Fajgenbaum DC; Rader DJ
    Cell Metab; 2020 Aug; 32(2):145-147. PubMed ID: 32755604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
    Otręba M; Kośmider L; Rzepecka-Stojko A
    Eur J Pharmacol; 2020 Nov; 887():173553. PubMed ID: 32949606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: A Defining Moment for Clinical Pharmacology?
    van der Graaf PH; Giacomini KM
    Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactive Psychosis in a Health Care Worker During the COVID-19 Pandemic.
    Rivas VCMO; Hernández-Huerta D; Silva CPD; Gómez-Arnau J
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32649065
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatry and COVID-19: The Role of Chlorpromazine.
    Stip E
    Can J Psychiatry; 2020 Oct; 65(10):739-740. PubMed ID: 32536208
    [No Abstract]   [Full Text] [Related]  

  • 13. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential Unconventional Medicines for the Treatment of SARS-CoV-2.
    Coppola M; Mondola R
    Drug Res (Stuttg); 2020 Jun; 70(6):286. PubMed ID: 32428941
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 and the safety margins of cell-based biological medicinal products.
    Modrof J; Kerschbaum A; Farcet MR; Niemeyer D; Corman VM; Kreil TR
    Biologicals; 2020 Nov; 68():122-124. PubMed ID: 32891497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can an Old Ally Defeat a New Enemy?
    Gurbel PA; Bliden KP; Schrör K
    Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing.
    Jermain B; Hanafin PO; Cao Y; Lifschitz A; Lanusse C; Rao GG
    J Pharm Sci; 2020 Dec; 109(12):3574-3578. PubMed ID: 32891630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panic prescribing has become omnipresent during the COVID-19 pandemic.
    Caplan AL; Upshur R
    J Clin Invest; 2020 Jun; 130(6):2752-2753. PubMed ID: 32330122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.